Cilostazol and ginkgo for memory in older adults with diabetes
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether a combination of cilostazol (a blood flow medication) and ginkgo (a herbal supplement) can help protect memory and thinking skills in people over 60 with type 2 diabetes. You may join if your memory is slightly below normal but not severely impaired.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You are 60 years old or older
- Your memory test score is between 24 and 28 (mild forgetfulness, not dementia)
- Your blood sugar control is stable (HbA1c 10% or lower)
- You are not currently taking blood thinners or other memory medications
- You do not have severe depression, active infections, or recent surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking cilostazol and aspirin together can help prevent heart attacks, strokes, and other cardiovascular events in people with type 2 diabetes who have early signs of artery disease or metabolic syndrome. It aims to see if this combination is more effective than aspirin alone.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
This trial studies whether Ginkgo biloba, a natural supplement, can affect certain blood markers in people with mild cognitive impairment (MCI). It may help show how the supplement works in the body and whether it could be a helpful option for early memory problems.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This trial tests whether the diabetes drug canagliflozin can help people with type 2 diabetes and mild cognitive impairment. It may slow down memory and thinking problems while also improving blood sugar control.
This study tests if a special computer-based brain training program can help improve thinking and memory in older adults with diabetes who are at risk for dementia. It might help keep your mind sharp as you age.
Hear when a new Cognitive Ability, General trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.